Issue 70, 2020

Controlled drug delivery for cancer cell treatment via magnetic doxorubicin imprinted silica nanoparticles

Abstract

Herein, we report a facile and rapid one-step synthetic strategy for the development of magnetic doxorubicin imprinted silica nanoparticles for drug release experiments in living cells showing a remotely triggered doxorubicin release upon applying an alternating magnetic field, without temperature elevation of the medium (local heating).

Graphical abstract: Controlled drug delivery for cancer cell treatment via magnetic doxorubicin imprinted silica nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
19 Feb 2020
Accepted
28 Jul 2020
First published
31 Jul 2020

Chem. Commun., 2020,56, 10255-10258

Controlled drug delivery for cancer cell treatment via magnetic doxorubicin imprinted silica nanoparticles

M. Nerantzaki, A. Michel, E. Briot, J. M. Siaugue, C. Ménager, C. Wilhelm and N. Griffete, Chem. Commun., 2020, 56, 10255 DOI: 10.1039/D0CC01325K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements